Emily Larrimer Savas

Emily Larrimer Savas

Troutman Pepper Locke

Contact
View Bio
RSS

Latest Posts › Food and Drug Administration (FDA)

Share:

Restricted Distribution Patent Claims ‎Are Not Method-of-Using Claims for the Purpose of ‎‎Listing in ‎FDA’s Orange Book

In the Hatch-Waxman arena of patent litigation, the crisscross of patent laws and FDA regulations is always in play. In the recent Federal Circuit decision in Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC,...more

3/3/2023  /  Food and Drug Administration (FDA) , Hatch-Waxman , Intellectual Property Protection , Patent Infringement , Patent Litigation , Patents , Pharmaceutical Industry , Pharmaceutical Patents
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide